|
Assessment of quality of life in a cohort of newly diagnosed patients on haart regimen, in resource restricted tribal region of chhattisgarh, India: A prospective study
Harminder Singh1, Kamalpreet Kaur1, Navin Dulhani2, Akash Bansal3, Bithika N Kumar4, Vinod Kumar Singh Chouhan5
1 Government Medical College, Jagdalpur, Chhattisgarh, India
2 Department of Medicine, Government Medical College, Jagdalpur, Chhattisgarh, India
3 Department of Biochemestry, Government Medical College, Jagdalpur, Chhattisgarh, India
4 Department of Pharmacology, Government Medical College, Jagdalpur, Chhattisgarh, India
5 Department of SPM, Government Medical College, Jagdalpur, Chhattisgarh, India
Correspondence Address:
Harminder Singh
Government Medical College, Jagdalpur, Chhattisgarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-777X.116870
|
|
Background: Highly active antiretroviral therapy regimens have resulted in the systemic/clinical healing for human immune deficiency virus-infected patients but the consequence of antiretroviral therapy on the whole quality of life has become a major concern. The current study correlates the relationship of quality of life with successful highly active antiretroviral therapy. Aim : To determine the health-related quality of life in human immune deficiency virus-infected patients on highly active anti-retroviral therapy regimen in tribal region of Chhattisgarh. Design: An open label prospective study. Materials and Methods: Health-related quality of life was assessed using a standardized questionnaire, the Medical Outcomes Survey Short Form 36. Physical health summary scores and mental health summary scores were compared of pre-Highly Active Anti-Retroviral Therapy (at baseline) and post 12 months of therapy. Results: The increase in CD4 cell counts was extremely significant (P < 0.0001). The Physical Composite Summary (P value = 0.0003) improved significantly, whereas the Mental Composite Summary (with a baseline value of 40.7), post 12 months, was calculated as 42.8 (P value = 0.2371) and was statistically not significant. Conclusion: Efficacy measurement is the key ingredient of highly active anti-retroviral therapy, which must also include assessment of health-related quality of life to maximize the holistic approach towards disease. |
